As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.
Hereditary orotic aciduria is a unique, potentially life-threatening, genetic disorder that hinders the synthesisation of adequate amounts of uridine in the patient, and results in suffering from hematologic abnormalities, a range of developmental delays, failure to thrive, and episodes of crystalluria resulting in obstructive uropathy.
The market is being driven by the constant innovation and launches by the key industry players, such as Merck & Co., Inc. (NYSE: MRK) and Wellstat Therapeutics Corporation. In September 2015, Wellstat Therapeutics Corporation announced that the US Food and Drug Administration (FDA) approved a treatment known as uridine triacetate (Xuriden) for hereditary orotic aciduria treatment. Along with the approval of XURIDEN for the medication of HOA, the FDA has also granted the company, Wellstat Therapeutics, a Rare Pediatric Disease Priority Review Voucher. XURIDEN was made available commercially in early 2016. The rising healthcare awareness is expected to further aid the market growth in the forecast period.
Market Analysis by Drug Type, Indication, Distribution Channel, and Region:
Key Findings of the Report:
Key Offerings of the Report:
Merck & Co. Inc. and Wellstat Therapeutics Corporation, among others, are the key players in the global hereditary orotic aciduria treatment market. The EMR report looks into the capacity, market share, and latest developments of these major players like plant turnarounds, mergers and acquisitions, and capacity expansions.
Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.
EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over a 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.
Expert Market Research
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.